Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often highlight the possibility for substantial therapeutic gains, principally in conditions where conventional treatments have proven inadequate. However, crucially important to consider the substantial financial investment associated with